Insufficient scRNA-seq data for expression of ROBO3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 1459.93 | 2626 / 2642 | 100% | 15.51 | 704 / 705 |
ovary | 100% | 7006.21 | 180 / 180 | 93% | 5.94 | 398 / 430 |
prostate | 100% | 2066.32 | 244 / 245 | 91% | 3.99 | 459 / 502 |
uterus | 99% | 1377.73 | 168 / 170 | 82% | 4.25 | 375 / 459 |
lung | 100% | 1474.72 | 577 / 578 | 78% | 3.30 | 898 / 1155 |
thymus | 100% | 1883.72 | 652 / 653 | 73% | 2.29 | 443 / 605 |
kidney | 96% | 957.18 | 85 / 89 | 77% | 2.94 | 692 / 901 |
skin | 79% | 623.87 | 1437 / 1809 | 91% | 4.48 | 429 / 472 |
breast | 100% | 1913.20 | 459 / 459 | 68% | 1.92 | 761 / 1118 |
bladder | 100% | 1054.05 | 21 / 21 | 67% | 2.60 | 337 / 504 |
esophagus | 97% | 1117.36 | 1399 / 1445 | 65% | 2.03 | 119 / 183 |
intestine | 98% | 1321.93 | 945 / 966 | 57% | 1.44 | 303 / 527 |
adrenal gland | 100% | 1721.01 | 258 / 258 | 41% | 1.11 | 95 / 230 |
pancreas | 30% | 137.20 | 98 / 328 | 93% | 4.03 | 166 / 178 |
stomach | 66% | 526.58 | 238 / 359 | 55% | 1.33 | 156 / 286 |
adipose | 100% | 3085.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 2491.73 | 241 / 241 | 0% | 0 | 0 / 0 |
liver | 38% | 173.05 | 87 / 226 | 61% | 1.74 | 246 / 406 |
blood vessel | 94% | 952.10 | 1250 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 2.39 | 68 / 80 |
heart | 83% | 724.45 | 711 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 1.91 | 22 / 29 |
tonsil | 0% | 0 | 0 / 0 | 58% | 1.88 | 26 / 45 |
muscle | 22% | 101.80 | 177 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 20% | 90.16 | 182 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016199 | Biological process | axon midline choice point recognition |
GO_1902669 | Biological process | positive regulation of axon guidance |
GO_0006935 | Biological process | chemotaxis |
GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
GO_0070593 | Biological process | dendrite self-avoidance |
GO_0007411 | Biological process | axon guidance |
GO_0030424 | Cellular component | axon |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0098632 | Molecular function | cell-cell adhesion mediator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | ROBO3 |
Protein name | ROBO3 protein Roundabout homolog 3 (Roundabout-like protein 3) Roundabout guidance receptor 3 |
Synonyms | |
Description | FUNCTION: Receptor involved in axon guidance during development . Acts as a multifunctional regulator of pathfinding that simultaneously mediates NELL2 repulsion, inhibits SLIT repulsion, and facilitates Netrin-1/NTN1 attraction. In spinal cord development plays a role in guiding commissural axons probably by preventing premature sensitivity to Slit proteins thus inhibiting Slit signaling through ROBO1/ROBO2. Binding OF NELL2 to the receptor ROBO3 promotes oligomerization of ROBO3, resulting in the repulsion of commissural axons in the midline. ROBO3 also indirectly boosts axon attraction to NTN1 without interacting with NTN1 itself (By similarity). . |
Accessions | F5H0K7 ENST00000543966.5 Q96HH0 ENST00000397801.6 [Q96MS0-1] ENST00000538940.5 F5GWJ5 Q96MS0 |